HSD17B13

Hydroxysteroid 17-Beta Dehydrogenase 13

Gene Information Card

Symbol HSD17B13
Full Name Hydroxysteroid 17-Beta Dehydrogenase 13
Gene Type Protein coding
Chromosomal Location 4q22.1
NCBI Gene ID 345275 ncbi.nlm.nih.gov/gene/345275
Ensembl ID ENSG00000170509
UniProt ID Q7Z5P4
OMIM ID 612127
HGNC ID 30189
Aliases SDR16C3, RDHS, 17-beta-HSD 13

Description

HSD17B13 encodes a member of the short-chain dehydrogenases/reductases (SDR) family. The protein functions as a retinol dehydrogenase, catalyzing the oxidation of retinol to retinaldehyde. It is predominantly expressed in the liver and has been implicated in lipid metabolism and the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). A common loss-of-function variant (rs72613567) is associated with reduced risk of chronic liver disease.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Non-alcoholic fatty liver disease (NAFLD) Loss-of-function variant reduces hepatic lipid accumulation and inflammation GWAS and cohort studies (PMID: 29771307, 29771306)
Non-alcoholic steatohepatitis (NASH) Protective variant decreases steatosis and fibrosis progression Human genetic association and functional studies (PMID: 29771308)
Alcoholic liver disease Variant associated with lower risk of alcoholic cirrhosis Cohort study (PMID: 29771307)
Chronic liver disease HSD17B13 loss-of-function protects against liver injury Meta-analysis (PMID: 29771306)

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 32.4 High
Adipose tissue 1.2 Low
Kidney 0.8 Low
Lung 0.5 Not detected
Heart 0.3 Not detected
Cell Line Expression
Cell Line nTPM Notes
HepG2 15.2 Hepatocellular carcinoma cell line
Huh7 12.8 Hepatoma cell line
Primary human hepatocytes 28.5 Normal liver cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
rs72613567 (TA insertion) Insertion ~30% in European populations Loss-of-function; reduced risk of NAFLD and NASH
rs6834314 SNP ~35% in European populations Associated with decreased liver enzyme levels
rs62305723 Missense (Pro260Ser) <1% Likely benign; no known disease association
Mutation functional classification

Loss of Function (LOF)

rs72613567 (TA insertion) leads to a truncated, non-functional protein, reducing hepatic lipid droplet accumulation and protecting against steatohepatitis.

Gain of Function (GOF)

No gain-of-function variants have been reported in HSD17B13.

Dominant Negative (DN)

No dominant-negative variants have been described for HSD17B13.

Pathways

Retinol metabolism (Reactome: R-HSA-975634)
Metabolism of lipids (Reactome: R-HSA-556833)

Protein Summary

HSD17B13 is a 317-amino acid protein localized to the cytoplasm, with highest expression in hepatocytes. It belongs to the short-chain dehydrogenase/reductase family and exhibits retinol dehydrogenase activity, converting retinol to retinaldehyde. The protein is associated with lipid droplets and plays a role in hepatic lipid metabolism. Loss-of-function variants, particularly rs72613567, confer protection against non-alcoholic and alcoholic liver disease by reducing steatosis, inflammation, and fibrosis.

Related Products

Product name Cat.No. Species Gene ID
HSD17B13 Knockout HEK293 Cell Line EDJ-KQ17880 Human 345275 Details Get a Quote
HSD17B13 Knockout HeLa Cell Line EDJ-KQ59788 Human 345275 Details Get a Quote
HSD17B13 Knockout A-549 Cell Line EDJ-KQ68256 Human 345275 Details Get a Quote
HSD17B13 Knockout HCT 116 Cell Line EDJ-KQ76631 Human 345275 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: